‌

US Patent 9421207 Pharmaceutical compositions comprising pemetrexed and tromethamine

Patent 9421207 was granted and assigned to Fresenius Kabi Oncology PLC on August, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Fresenius Kabi Oncology PLC

Current Assignee

Fresenius Kabi Oncology PLC

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94212070

Patent Inventor Names

Mukti Yadav0

Dhiraj Khattar0

Krishanu Burman0

Rajesh Khanna0

Date of Patent

August 23, 2016

Patent Application Number

144033100

Date Filed

May 30, 2013

Patent Citations Received

‌

US Patent 12115164 Pemetrexed formulations

‌

US Patent 11931362 Stable pharmaceutical formulations of pemetrexed

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

A pharmaceutical composition of Pemetrexed represented by formula (I),

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9421207 Pharmaceutical compositions comprising pemetrexed and tromethamine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API